BÖLÜM


DOI :10.26650/B/CH32.2024.010.027   IUP :10.26650/B/CH32.2024.010.027    Tam Metin (PDF)

Mali̇gni̇tesi̇ Olan Çocuğun İzlemi̇ ve Toplumda Bakımı-Kanser Sonrası Yaşam

Hikmet Gülşah TanyıldızDeniz Tuğcu

Çocukluk çağında, 15 yaş altında kanser görülme oranı yaklaşık milyonda 140’tır. Dünyada her sene 18 milyon kişi kanser tanısı almakta ve yaklaşık 9.6 milyon kişi buna bağlı olarak kaybedilmektedir. Erişkinlerde ölüm nedenleri arasında ikinci sırada, çocuklarda ise ilk sırada yer almaktadır. Olumlu bir gelişme olarak son yıllarda tanı yöntemlerindeki ve destekleyici bakımdaki gelişmeler sayesinde birçok kanser tanısında genel sağkalım oranları %80’lere ulaşmıştır. Kanserden sonra yaşam, farklı ve hassas takip gerektiren bir süreçtir ve bunun profesyonel bir şekilde planlanması gerekir. Kanser tedavisi sonrası yan etkilerin çoğu yıllar sonra ortaya çıkmaktadır. Tedavinin geç komplikasyonları organ büyümesi, gelişimi ve işlevi, nörobilişsel ve akademik başarı ile ilgili sorunları ve ikincil kanser riskini içerir. Kanser ve tedavisi aynı zamanda aile/akran ilişkilerini, mesleki ve istihdam fırsatlarını, sigorta ve sağlık hizmetlerine erişimi olumsuz etkileyebilecek önemli psikososyal sonuçlara da sahiptir. Kanser deneyimi bir çocuğun hayatını uzun süreli değiştirir; çocuğa ve aileye rehabilitasyon konusunda yardımcı olmak çok önemlidir. Sağ kalanların yaklaşık %73’ü tanıdan sonraki 30 yıl içinde en az bir kronik sağlık sorunu ile karşılaşmaktadır ve bunların %42’si hayatı tehdit eden bir sorun olmaktadır. Hedef, çocukların tedavi bitiminden sonra daha kaliteli bir yaşam sürdürmelerini sağlamaktır. Kanserden iyileşmiş çocukların, uzun dönem izlemi ulusal bir politika olarak önemsenmelidir.


Anahtar Kelimeler: Pediatrik kansersağkalanizlem
DOI :10.26650/B/CH32.2024.010.027   IUP :10.26650/B/CH32.2024.010.027    Tam Metin (PDF)

Follow-up and Community Care of the Child with Malignancy: Life After Cancer

Hikmet Gülşah TanyıldızDeniz Tuğcu

The incidence of cancer among children aged below 15 years is approximately 140 per million. Every year, 18 million people worldwide are diagnosed with cancer, and approximately 9.6 million people die as a result. Cancer is the second leading cause of death in adults and the first in children. However, thanks to advances in diagnostic methods and supportive care in recent years, the overall survival rates in many cancer cases have reached 80%. Life after cancer requires a different and sensitive follow-up and thus needs to be professionally planned. As most of the side effects after treatment appear years later, approximately 73% of survivors experience at least one chronic health condition within 30 years of diagnosis, and 42% of which are life-threatening. Late complications of treatment include problems with organ growth, development and function, decline in neurocognition and academic achievement, and the potential for secondary cancers. Cancer and its treatment also have significant psychosocial consequences that can negatively affect family/peer relationships, occupational and employment opportunities, and access to insurance and health care. A child’s life is forever changed in cancer. Assisting the child and family during rehabilitation is essential to achieve a better quality of life. As per national policy, long-term follow-up of children who have recovered from cancer should be considered.


Anahtar Kelimeler: Pediatric cancersurvivorfollow-up

Referanslar

  • 1. Kimberly D. Miller; Leticia Nogueira ; Theresa Devasia,; Angela B. Mariotto, ; K. Robin Yabroff; Ahmedin Jemal, et al; Siegel. Cancer treatment and survivorship statistics, 2022. Ca Cancer J Clin 2022;72:409-436. google scholar
  • 2. The Cancer Atlas. Canser in Children. Erişim: https://canceratlas.cancer.org/the-burden/cancer-in-children/. Son erişim tarihi: 25.08.2023. google scholar
  • 3. Kebudi R. Pediatric oncology in Turkey. Journal of pediatric hematology/oncology. 2012;34:12-14. google scholar
  • 4. Kutluk MT, Yesilipek A. Pediatric cancer registry Turkey: 2009-2016 (TPOG &TPHD). In: American Society of Clinical Oncology; 2017. google scholar
  • 5. Kebudi R, Alkaya DU. Epidemiology and survival of childhood cancer in Turkey.Pediatric Blood and Cancer 2021; 68 :e28754. google scholar
  • 6. Kaatsch P. Epidemiology of childhood cancer. Cancer Treatment Reviews 36 (2010) 277-285. google scholar
  • 7. Kimberly D. Miller; Leticia Nogueira ; Theresa Devasia,; Angela B. Mariotto, ; K. Robin Yabroff; Ahmedin Jemal, et al; Siegel. Cancer treatment and survivorship statistics, 2022. Ca Cancer J Clin 2022;72:409-436. google scholar
  • 8. Türk Pediatrik Onkoloji Grubu. TPOG Uzun Dönem İzlem Rehberi. 2019. Erişim: https://tpog.org.tr/tpog-u-zun-donem-izlem-rehberi-udir/. Son erişim tarihi: 25.08.2023. google scholar
  • 9. Kathryn E. Weaver, Laura P. Forsythe, Bryce B. Reeve, Catherine M. Alfano, et al. Mental and physical health-re-lated quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012; 21: 2108- 2117. google scholar
  • 10. Berry LL, Davis SW, Godfrey Flynn A, Landercasper J, Deming KA. Is it time to reconsider the term “cancer survivor?” J Psychosoc Oncol. 2019; 37: 413- 426. google scholar
  • 11. Keats MR, Shea K, Parker L, Stewart SA, Flanders A, Bernstein M. After Childhood Cancer: a Qualitative Study of Family Physician, Parent/Guardian, and Survivor Information Needs and Perspectives on Long-Term Follow-up and Survivorship Care Plans. J Cancer Educ 2019; 34: 638-646. google scholar
  • 12. Kevin C. Oeffinger, Ann C. Mertens, Charles A. Sklar, Toana Kawashima, Melissa M. Hudson, Anna T. Meadows et al. for the Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med, 2006. 355(15): p. 1572-82.2. google scholar
  • 13. İncesoy Özdemir S, Taçyıldız N, Varan A, Kebudi R, Zülfikar OB, Celkan TT, et al. M. Cross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives. Turk J Med Sci. 2020; 50 :1916-1921. google scholar
  • 14. Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med. 2002;21:3511-3526. google scholar
  • 15. Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 8.3.9. National Cancer Institute; 2021. google scholar
  • 16. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7-33. google scholar
  • 17. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American As-sociation of Central Cancer Registries Incidence— Cancer in North America Analytic File, 1995-2018, with Race/Ethnicity, Custom File With County, American Cancer Society Facts and Figures Projection Project. North American Association of Central Cancer Registries; 2019. google scholar
  • 18. Liu B, Zhu L, Zou J, et al. Updated methodology for projecting U.S.- and state-level cancer counts for the current calendar year: part I: spatio-temporal modeling for cancer incidence. Cancer Epidemiol Biomarkers Prev. 2021;30(9): 1620-1626. google scholar
  • 19. Maud M. Geenen, Mathilde C. Cardous-Ubbink, Leontien C. M. Kremer, Cor van den Bos, Helena J. H. van der Pal, Richard C. Heinen, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. Jama 2007; 297: 2705-15.3. google scholar
  • 20. Kean S, Donaghy E, Bancroft A, Clegg G, Rodgers S. Theorising survivorship after intensive care: A systematic review of patient and family experiences. J Clin Nurs. 2021;30:2584-2610. google scholar
  • 21. Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon et al. Survivorship: Immunizations and Prevention of Infections, Version 2.2014: J Natl Compr Canc Netw. 2014;12(8): 1098-1111. google scholar
  • 22. Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon et al. Survivorship: Immunizations and Prevention of Infections, Version 2.2014: J Natl Compr Canc Netw. 2014;12: 1098-1111. google scholar
  • 23. Pollock NI, Cohen LE. Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors. Front Endocrinol (Lausanne). 2021 Oct 22;12:745932. google scholar
  • 24. Duffy C, Allen S. Medical and Psychosocial Aspects of Fertility After Cancer. Medical and Psychosocial Aspects of Fertility After Cancer. Cancer J. 2009; 15: 27-33. google scholar
  • 25. Mulder RL, Font-Gonzalez A, Hudson MM, et al.; PanCareLIFE Consortium. Fertility preservation for fe-male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021; 22: e45-e56. google scholar
  • 26. Mulder RL, Font-Gonzalez A, van Dulmen-den Broeder E, et al. PanCareLIFE Consortium. Communica-tion and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021; 22: e68-e80. google scholar
  • 27. Mulrooney DA, Hyun G, Ness KK, Ehrhardt MJ, Yasui Y, Duprez D. et al. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survi-vor Study cohort. BMJ 2020;368:l6794. google scholar
  • 28. Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: a systematic review. Chest. 2011; 140: 881-901. google scholar
  • 29. Esmee C.M. Kooijmans, Helena J.H. van der Pa, Saskia M.F. Pluijm, Margriet van der Heiden-van der Loo, Leontien C.M. Kremer, Dorine Bresters et al, on behalf of the Dutch LATER study group. The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors. Kidney International 2022:102, 1136-1146. google scholar
  • 30. Kenborg L, Winther JF, Linnet KM, Kroyer S, Albieri V, Holmqvist AS. et al; ALiCCS study group. Neuro-logic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Chil-dhood Cancer in Scandinavia (ALiCCS) study Neuro Oncol 2019; 21: 125-136. google scholar
  • 31. Kimberly FW, Stratton K, Kawashima T, Waterbor JW, Castleberry RP, Stovall M. et al. Ocular Late Effe-cts in Childhood and Adolescent Cancer Survivors: A Report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2010; 54: 103-109. google scholar
  • 32. Morland B, Bouffet E, Rutkowski S, Tytgat GAM, Geller JI, Hunter LL, et al. Society of Paediatric Onco-logy Supportive Care Committee. Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric On-cology Supportive Care Consensus Report. JAMA Oncol. 2021;7:1550-1558. google scholar
  • 33. Stolze J, Vlaanderen KCE, Holtbach FCED, Teepen JC, Kremer LCM, Loonen JJ. et al. Long-Term Effects of Childhood Cancer Treatment on Dentition and Oral Health: A Dentist Survey Study from the DCCSS LATER 2 Study. Cancers (Basel) 2021; 13: 5264. google scholar
  • 34. Costanzo ES, Ryfff CD, Singer BH, Psychosocial Adjustment Among Cancer Survivors: Findings From a National Survey of Health and Well-BeingHealth Psychol. 2009; 28: 147-156. google scholar


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.